Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 02 04:00PM ET
0.6040
Dollar change
-0.0160
Percentage change
-2.58
%
Index- P/E- EPS (ttm)-0.08 Insider Own0.32% Shs Outstand411.11M Perf Week6.53%
Market Cap248.31M Forward P/E- EPS next Y-0.21 Insider Trans13.85% Shs Float409.78M Perf Month-3.44%
Income-33.45M PEG- EPS next Q-0.06 Inst Own19.45% Short Float4.45% Perf Quarter-12.00%
Sales265.09M P/S0.94 EPS this Y-13.33% Inst Trans-7.25% Short Ratio15.15 Perf Half Y-43.02%
Book/sh1.34 P/B0.45 EPS next Y-23.53% ROA-4.03% Short Interest18.23M Perf Year-28.65%
Cash/sh0.75 P/C0.81 EPS next 5Y38.90% ROE-5.97% 52W Range0.56 - 1.37 Perf YTD-30.57%
Dividend Est.- P/FCF- EPS past 5Y17.93% ROI-5.97% 52W High-55.91% Beta1.92
Dividend TTM- Quick Ratio2.01 Sales past 5Y14.60% Gross Margin55.41% 52W Low6.90% ATR (14)0.03
Dividend Ex-Date- Current Ratio3.04 EPS Y/Y TTM13.44% Oper. Margin-14.85% RSI (14)48.62 Volatility5.41% 4.18%
Employees275 Debt/Eq0.01 Sales Y/Y TTM-23.65% Profit Margin-12.62% Recom3.50 Target Price1.00
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q108.56% Payout- Rel Volume0.44 Prev Close0.62
Sales Surprise32.29% EPS Surprise100.00% Sales Q/Q-15.99% EarningsJul 31 BMO Avg Volume1.20M Price0.60
SMA201.41% SMA50-5.25% SMA200-29.69% Trades Volume531,412 Change-2.58%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Resumed JP Morgan Underweight
Oct-25-23Downgrade Jefferies Buy → Hold $3 → $1
Jan-06-23Upgrade Jefferies Hold → Buy $1.30 → $3
May-06-22Downgrade JP Morgan Neutral → Underweight
May-05-22Downgrade SVB Leerink Outperform → Mkt Perform $10 → $3
May-05-22Downgrade H.C. Wainwright Buy → Neutral $10 → $3
May-04-22Downgrade Northland Capital Outperform → Market Perform
May-12-21Downgrade Goldman Neutral → Sell $6 → $5
Sep-29-20Resumed JP Morgan Neutral
Aug-26-20Initiated Piper Sandler Overweight $21
Oct-01-24 08:00AM
Sep-09-24 07:30AM
Aug-22-24 08:30AM
Aug-01-24 12:59PM
Jul-31-24 02:15PM
07:00AM Loading…
07:00AM
Jul-29-24 02:26PM
Jul-17-24 04:15PM
08:00AM
Jul-08-24 07:30AM
Jun-04-24 07:30AM
May-28-24 08:15AM
May-06-24 08:00AM
May-03-24 10:16AM
09:40AM
12:35PM Loading…
May-01-24 12:35PM
11:54AM
11:00AM
08:35AM
07:30AM
07:00AM
Apr-24-24 02:00PM
Apr-22-24 08:00AM
Apr-15-24 08:00AM
Apr-08-24 08:00AM
06:30AM
Apr-06-24 03:30PM
Apr-04-24 01:20PM
Apr-03-24 04:13PM
08:00AM
08:00AM Loading…
Mar-25-24 08:00AM
Mar-01-24 09:30AM
08:39AM
Feb-29-24 03:30PM
07:37AM
07:34AM
07:00AM
Feb-15-24 08:00AM
Jan-22-24 07:30AM
Jan-12-24 09:40AM
Jan-11-24 09:34AM
Jan-10-24 07:02PM
07:00AM
Dec-26-23 07:13PM
Dec-11-23 08:00AM
Dec-05-23 12:00PM
Nov-12-23 09:00AM
Nov-02-23 10:58AM
Nov-01-23 12:30PM
12:03PM
09:30AM
09:25AM
07:30AM
07:00AM
Oct-31-23 12:00PM
Oct-26-23 08:00AM
Oct-23-23 10:08AM
Oct-19-23 08:00AM
Sep-12-23 08:00AM
Aug-24-23 09:29AM
Aug-19-23 11:22AM
Aug-09-23 04:05PM
Aug-08-23 07:00AM
Aug-07-23 07:00AM
Aug-03-23 11:22AM
Aug-02-23 07:33AM
07:11AM
Jul-31-23 08:00AM
Jul-28-23 02:56PM
Jul-26-23 08:00AM
Jul-25-23 04:05PM
Jul-20-23 08:00AM
Jul-19-23 12:58PM
11:19AM
Jul-18-23 04:16PM
04:15PM
Jul-05-23 11:43AM
Jun-21-23 09:00AM
Jun-08-23 11:07AM
Jun-01-23 04:30PM
06:00AM
May-23-23 09:50AM
May-12-23 11:00AM
May-03-23 02:00PM
01:47PM
07:41AM
07:00AM
May-02-23 01:32PM
Apr-19-23 08:00AM
Apr-17-23 07:00AM
Apr-13-23 10:18AM
Apr-12-23 09:18AM
Apr-04-23 03:53PM
08:00AM
Mar-16-23 08:00AM
Mar-06-23 04:05PM
09:37AM
08:00AM
Mar-05-23 10:21AM
Mar-03-23 11:09AM
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Berg AaronPresident and CEOAug 02 '24Buy0.64160,000102,400805,380Aug 05 05:30 PM
Holt PatrickPresident and CEOJan 22 '24Buy1.0914,42615,724314,426Jan 24 04:31 PM
Ketchum Steven BChief Scientific OfficerDec 12 '23Sale0.7934,13126,963566,100Dec 14 06:35 PM